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Until now the results on profiling dopamine receptors in C. elegans have been incomplete and fragmentary. The
aim of this study was to in- vestigate the expression profile of dop-1 gene in C. elegans using 3 kb promoter with
3'-end locating before ATG of dop-1gene. Methods. The strain of C. elegans with mutant unc-119 gene was used.
To check a pat- tern of the dop-1 expression, the promoter of this gene was amplified using PCR. The animals
were co-bombarded with plasmid pPD95.77 dop-1::GFP and reporter construct containing unc-119 gene.
Results. Using GFP as a reporter protein, we built a whole picture of expres- sion of dopamine receptor type 1 in
C. elegans and found that this pro- tein could be detected only in mechanosensory neurons such as PLM, PVQR,
PVQL, ALNR, ALNL, DVAR, DVC.
Keywords: dopamine receptors, mechanosensory neurons, Caeno- rhabditis elegans, expression.
Introduction. Dopamine is one of the most essential
neurotransmitters for many animals – from nematodes
to mammals. In humans it participates in the regulation
of locomotor activity, thinking, emotional state, etc [1].
The disorder in metabolism of this compound may
result in a series of wide-spread human diseases, inclu-
ding schizophrenia, Parkinson disease, and Tourette
syn- drome [2].
Plant parasitic nematode C. elegans was used as a
model organism for over 20 years [3]. Recently its ap-
plication has been extended to the simulation of neuro-
degenerative pathologies and design of medical
preparations [4]. Therefore, a detailed investigation of
the nervous system, including the metabolism of
neuromediators and their receptors in C. elegans, is
rather urgent.
There are four known dopamine receptors which
(by analogy to human receptors) are divided into two
families: D1, including receptor type 1 (dop-1), and D2,
including types 2–4 receptors (dop-2-4) [2].
Previous research on the expression profile of do-
pamine receptor type 1 revealed rather ambiguous re-
sults as the works demonstrated different patterns of
neurons, where a reporter construction was expressed.
This can be explained by uneven length and structure of
promoters, used in these works [5–7]. Therefore, it was
decided to conduct a more detailed analysis of expres-
sion profile of dop-1 in C. elegans, using 3 kb promoter
with 3’-end locating before ATG of the dop-1 gene.
The promoter length was selected based on the task of
obtaining the most specific expression pattern, inde-
pendent from other DNA regulating elements, which
may be located in longer promoters and cause the ex-
pression of the reporter protein in non-target neurons.
Materials and Methods. Strains. The strain C.
elegans with a mutant unc-119 gene, leading to almost
complete paralysis of animals, was used. The strain was
obtained from the Genetic Center of Caenorhabditis
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(USA). The cultivation was conducted on Petri dishes
with NGM-agar. The nutrient medium was Escherichia
coli bacteria of OP50 strain (OP-50).
Genetic constructions. To check the expression pat-
tern of dop-1, 3 kb promoter of this gene was amplified
using a protocol of single worm polymerase chain
reaction (PCR) [8]. Then the promoter of dop-1 gene
was built into pPD95.77 (Add-gene, USA) at restriction
sites HindIII and Cfr9I to obtain the construction
pPD95.77dop-1: GFP (Fig.1).
Gene bombardment of C. elegans. Animal cells
were co-bombarded with plasmid pPD95.77dop-1:
:GFP and reporter construction pRH21Unc119 (Prof.
A. Fire’s lab, USA) with unc-119 gene, promoting res-
toration of the wild phenotype. The bombardment was
performed using PDS-1000/He system (Biorad, USA)
with the pressure of 9.3 MPa and 711 mm Hg in the
chamber.
The delivery of DNA was performed using gold na-
noparticles, covered with linearized plasmid DNA in
3:1 ratio by a standard method [9]. Two days prior to
bombardment the C. elegans culture was synchronized,
and 1 hour prior to the experiment it was transferred to
dishes without bacteria. After bombardment the culture
was incubated for 30 min at room temperature and
sown to dishes with NGM agar and OP50.
The screening was started 3 days after bombar-
dment and continued for 10 days using light and
confocal microscopes.
Results and Discussion. The visualization of GFR
expression under the control of the promoter of dop-1
gene revealed that the expression of the target protein is
mainly registered in the neurons of the head and tail
(Fig.2, a, b). In the tail of the experimental animals
GFR was revealed in neurons PLM, PVQR, PVQL,
ALNR, ALNL, DVAR, DVC (Fig.2, a). In the head of
animals the fluorescence of GFR was detected in
neurons CEPDL and CEPDR as well as in a numerous
group of cells, surrounding the nervous ring (Fig.2, b),
belonging to the mechanosensory neurons, accountable
for the response to soft touches. Besides the cranial and
caudal compartments, GFP was expressed in
mechanosensory neurons PVM and AVM, located in
the medium part of C. elegans body (Fig.2, a, c).
As GFP expression is registered only in the
mechanosensory neurons it can be concluded that the
dopamine receptor type 1 should determine the res-
ponse to mechanic stimuli. This is indicated by the
previously obtained results of changes in the reactions
of animals with the dop-1 gene knockout to mechanic
stimuli. However, it is surprising that all the above-
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Fig. 1. Plasmid pPD95.77dop-1p::GFP
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Fig. 2. dop-1::GFP expression in neurons C. elegans (à – tail section; á – head section; â – midsection). VNC – ventricle nerve trunk
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mentioned neurons are not post-synaptic regarding
dopaminergic cells of C. elegans which may serve as
another confirmation of the hypothesis on the neuro-
endocrine effect of dopamine in the nervous system.
Conclusions. The expression profile of the 3 kb
promoter region of dopamin receptor type 1 of C. ele-
gans nematode was characterized using the expression
of reporter gfp gene, which allows employing these
results in future elaboration of new approaches to
search for the means of treating diseases, related to
impairment of the dopaminergic neurotransmission
system.
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Ðåçóëüòàòè äîñë³äæåíü åêñïðåñ³¿ äîôàì³íîâèõ ðåöåïòîð³â â C.
elegans íàðàç³ çàëèøàþòüñÿ íåïîâíèìè ³ ôðàãìåíòàðíèìè. Ìåòà
ðîáîòè ïîëÿãàëà ó âèâ÷åíí³ ïðîô³ëþ åêñïðåñ³¿ äîôàì³íîâîãî ðå-
öåïòîðà òèïó 1 (dop-1) â C. elegans ç âèêîðèñòàííÿì ïðîìîòîðó
ðîçì³ðîì 3 òèñ. ï. í., 3'-ê³íöåâà ïîñë³äîâí³ñòü ÿêîãî ðîçòàøîâàíà
ïåðåä êîäîíîì ATG ãåíà dop-1. Ìåòîäè. Êóëüòèâóâàííÿ øòàìó
C. elegans, ìóòàíòíîãî çà ãåíîì unc-119, ç àãàðîì NGM. Äëÿ ïå-
ðåâ³ðêè ïàòòåðíó åêñïðåñ³¿ dop-1 àìïë³ô³êîâàíî ïðîìîòîð ãåíà
ìåòîäîì ÏËÐ. Êë³òèíè òâàðèí êîáîìáàðäóâàëè ïëàçì³äîþ
pPD95.77dop-1::GFP òà ðåïîðòåðíîþ êîí- ñòðóêö³ºþ ç ãåíîì
unc-119. Ðåçóëüòàòè. ²ç çàñòîñóâàííÿì GFP ÿê ðåïîðòåðíîãî
á³ëêà âäàëîñÿ ïîâí³- ñòþ îõàðàêòåðèçóâàòè ïðîô³ëü åêñïðåñ³¿ äî-
ôàì³íîâîãî ðåöåïòîðà ïåðøîãî òèïó â C. elegans. Âèñíîâêè.
Ïðîäåìîíñòðîâàíî, ùî äàíèé á³ëîê åêñïðåñóºòüñÿ â ìåõàíîñåí-
ñîðíèõ íåéðîíàõ, òàêèõ ÿê PLM, PVQR, PVQL, ALNR, ALNL,
DVAR ³ DVC.
Êëþ÷îâ³ ñëîâà: äîôàì³íîâ³ ðåöåïòîðè, ìåõàíîñåíñîðí³ íåéðî-
íè, Caenorhabditis elegans, åêñïðåñ³ÿ.
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Äî íàñòîÿùåãî âðåìåíè ðåçóëüòàòû èññëåäîâàíèé ýêñïðåññèè äî-
ôàìèíîâûõ ðåöåïòîðîâ â C. elegans îñòàþòñÿ íåïîëíûìè è ôðàã-
ìåíòàðíûìè. Öåëü ðàáîòû ñîñòîÿëà â èçó÷åíèè ïðîôèëÿ ýêñïðå-
ñèè äîôàìèíîâîãî ðåöåïòîðà ïåðâîãî òèïà (dop-1) â C. elegans ñ
èñïîëüçîâàíèåì ïðîìîòîðà ðàçìåðîì 3 òûñ. ï. í., 3'-êîíöåâàÿ ïî-
ñëåäîâàòåëüíîñòü êîòîðîãî ðàñïîëîæåíà ïåðåä êîäîíîì ATG ãå-
íà dop-1. Ìåòîäè. Êóëüòèâèðîâàíèå øòàììà C. elegans, ìóòàíò-
íîãî ïî ãåíó unc-119, ñ àãàðîì NGM. Äëÿ ïðîâåðêè ïàòòåðíà ýêñ-
ïðåññèè dop-1 àìïëèôèöèðîâàëè ïðîìîòîð ãåíà ìåòîäîì ÏËÐ.
Êëåòêè æèâîòíûõ êîáîìáàðäèðîâàëè ïëàçìèäîé pPD95.77dop-1:
:GFP è ðåïîðòåðíîé êîíñòðóêöèåé ñ ãåíîì unc-119. Ðåçóëüòà-
òû. Ñ èñïîëüçîâàíèåì GFP â êà÷åñâå ðåïîðòåðíîãî áåëêà óäàëîñü
ïîëíîñòüþ îõàðàêòåðèçîâàòü ïðîôèëü ýêñïðåññèè äîôàìèíîâî-
ãî ðåöåïòîðà ïåðâîãî òèïà â C. elegans. Âûâîäû. Ïðîäåìîíñòðè-
ðîâàíî, ÷òî äàííûé áåëîê äåòåêòèðóåòñÿ â ìåõàíîñåíñîðíûõ íåé-
ðîíàõ, òàêèõ êàê PLM, PVQR, PVQL, ALNR, ALNL, DVAR è DVC.
Êëþ÷åâûå ñëîâà: äîôàìèíîâûå ðåöåïòîðû, ìåõàíîñåíñîðíûå
íåéðîíû, Caenorhabditis elegans, ýêñïðåññèÿ.
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